To better understand the effect of Aza on epigenetic marks and transcription profiles in MDS progenitors, we set out to assess changes in DNA methylation, chromatin marks and gene expression in primary MDS patient CD34+ cells, after short term incubation with Aza. This evidence concerns the gene CD34 and myelodysplastic syndrome.